JCR Pharmaceuticals Co.,Ltd. (4552) Stock Price

JCR Pharma manufactures, procures, and sells pharmaceutical products for medical use, regenerative medicine products, and pharmaceutical raw materials. The company aims to drive innovation in the healthcare field and provides a diverse range of products. Particularly in regenerative medicine, the company leverages advanced technology to contribute to patient treatment.

Chromatec Corporation, a JCR Pharma affiliate, handles procurement operations and the sourcing and sale of medical and research equipment. Through these activities, it plays a critical role in supporting JCR Pharma's product supply chain.

JCR Engineering Corporation manages facility operations. It provides the operational foundation necessary for the smooth running of JCR Pharma's manufacturing and research facilities.

JCR International S.A. conducts market research. This enables JCR Pharma to monitor market trends and apply insights to product development and sales strategies.

JCR USA, Inc. oversees the management and supervision of clinical trial outsourcing contracts. It supports JCR Pharma's new drug development process and ensures the efficient progress of clinical trials.

Armagen, Inc. handles pharmaceutical development and the management of intellectual property and licensing. Through these functions, it supports JCR Pharma's technological innovation and market expansion.

JCR do Brasil Pharma conducts clinical operations, regulatory affairs, and development activities in Brazil. This supports JCR Pharma's international business expansion.

Medipal Holdings Corporation has entered into a pharmaceutical development partnership with JCR Pharma. This collaboration leverages the technology and resources of both companies to advance new drug development.

JCR Europe B.V. handles clinical operations, regulatory affairs, and development activities in Europe. This strengthens JCR Pharma's presence in the European market.

JCR Luxembourg S.A. manages the distribution of pharmaceutical products and their raw materials. It ensures that JCR Pharma's products are efficiently supplied to the market.

Allied Cell Corporation conducts research and development, manufacturing, and sales of regenerative medicine products. This enhances JCR Pharma's competitive position in the regenerative medicine sector.

JCR Pharma marked its 50th anniversary by redefining its corporate mission and clarifying its commitment to addressing rare diseases and difficult treatment challenges. The company has established core values—"People," "Innovation," "Evolution," and "Excellence"—that all employees are expected to share, emphasizing responsibility to patients and healthcare professionals.

The company's medium-term management plan, "Reach Beyond, Together," aims to provide lysosomal disease treatments using its proprietary technology, J-Brain Cargo®. Under this plan, JCR Pharma is strengthening research and development and production capabilities, with particular focus on advancing clinical development overseas.

JCR Pharma prioritizes strengthening its business foundation domestically and internationally, pursuing stable business expansion. The company is pursuing a growth strategy that reduces reliance on domestic product sales and contract revenues from external partners, focusing on developing new drugs using biopharmaceutical and gene therapy technologies.

JCR Pharma aims to monitor changes in domestic and international policies and regulatory environments while deploying innovative pharmaceuticals based on its proprietary platform technologies to the global market. Through this approach, JCR Pharma seeks to continue driving innovation in healthcare and contributing to patient treatment.